关键词: Phenotypic screening 、 Computer science 、 In silico 、 Probabilistic logic 、 Quantitative structure–activity relationship 、 Pathway enrichment 、 Data integration 、 Scale (chemistry) 、 Bioinformatics 、 Computational biology 、 Human proteins
摘要: The advent of in silico compound target prediction offers a potential paradigm shift how large collections are understood and used strategically high-throughput screens (HTS). Specifically, phenotypic HTS hits may be annotated both with known targets predicted using large-scale QSAR models, enabling more sophisticated hit assessment. Efforts massive bioactivity data integration standardization is empowering such compound-target annotations. These approaches differ fundamentally from the traditional role lead optimization binding affinity predictions to global, probabilistic for thousands human proteins.